Biotech Customer Partnership August 3, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571) 272-0500

Slides:



Advertisements
Similar presentations
1 TC1600 Restriction Practice Action Plan and Unity of Invention Study Bruce Kisliuk Group Director, TC1600 United States Patent and Trademark Office.
Advertisements

1 Pre-Appeal Brief Conference (with Demo) By: Bennett Celsa Jean Witz Kathleen Bragdon TC1600 Quality Assurance Specialists.
The Examination Process
First Action Interview Pilot Program Overview. Pilot Program Objectives Promote personal interviews prior to issuance of a first Office action on the.
1 TC1600-Quality Assurance Bennett Celsa QAS Joseph Woitach SPE June 4, 2013.
Bicoastal Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting RCE Progress Update Daniel Sullivan Director, TC1600 September 17, 2014.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting October 8, 2002 William F. Smith Administrative Patent Judge Board of Patent Appeals.
Appeal Practice Before Board of Patent Appeals and Interferences
Enhanced First Action Interview (EFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
TC1600 Appeals Practice Jean Witz, Appeals Specialist.
July 8, Enhanced Examination Timing Control Robert A. Clarke Deputy Director Office of Patent Legal Administration
Accelerated Examination Bennett Celsa (TC 1600: QAS)
CSU Customer Service Directorate 2004 Survey Update CAPT Larry Kirwan 16 August 2004.
Money: NPCC Community Grants Program Rosalina James, PhD.
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Patent Quality Assurance Program. 2 Office of Patent Quality Assurance (OPQA) Deputy Commissioner for Patent Operations Office of Patent Quality Assurance.
Appeal Practice Refresher Office of Patent Training.
Current and Future USPTO Practice RESTRICTION PRACTICES AT THE USPTO 1 © AIPLA 2015.
Full First Action Interview (FFAI) Pilot Program Wendy Garber Tech Center Director, 2100 United States Patent & Trademark Office.
1 United States Patent and Trademark Office Revised PCT International Search and Preliminary Examination Guidelines Biotech/ChemPharm Customer Partnership.
Complex Work Unit Pilot Program Lisa J. Hobbs, Ph.D. Project Manager Search and Information Resources Administration Biotechnology/Chemical/Pharmaceutical.
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Anthony Caputa, Ph.D. Technology Center Practice Specialist TC 1600.
1 1 Interview Practice Within the USPTO. 2 2 Topics Effective Interviews Reaching Agreement Requesting Interviews Issues Discussed Documenting Interviews.
Customer Partnership Meeting John Doll Commissioner for Patents.
1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)
Restriction & Double Patenting Mojdeh Bahar, J.D., M.A., CLP Chief, Cancer Branch Office of Technology Transfer National Institutes of Health U.S. Department.
November 29, Global Intellectual Property Academy Advanced Patents Program Kery Fries, Senior Legal Advisor Mark Polutta, Senior Legal Advisor Office.
1 Biotechnology/Chemical/Pharmaceutical Customer Partnership June 1, 2010 Valencia Martin-Wallace – Director, Technology Center 2400.
1 Business Method Patents The USPTO Perspective Prepared for the Casualty Actuary Society Annual Meeting November 15, by John J. Love The United.
To Restrict or Not To Restrict That Is The Question? Divided We Stand! Or Undivided We Stand!! By Joseph K. McKane SPE, Art Unit 1626.
USPTO Patent Quality Composite presented to Biotechnology/Chemical/Pharmaceutical Customer Partnership September 5, 2012 by Martin Rater Statistician USPTO,
Appeals in patent examination and opposition in Germany Karin Friehe Judge, Federal Patent Court, Munich, Germany.
Pilot Concerning Public Submission of Peer Reviewed Prior Art Jack Harvey Director, TC 2100 United States Patent and Trademark Office
Election of Species Joseph K. McKane SPE, Art Unit 1626 April 27, 2004.
1 1 AIPLA American Intellectual Property Law Association Updates on the USPTO Chris Fildes AIPLA-JPAA Joint Meeting April 9, 2013.
Common Manual: Unified Student Loan Policy Becca Diskin MASFAP Conference March 7, 2007.
1 When is it NOT Appropriate to Restrict? Julie Burke TC1600 QAS
Christian Chace Patent Process Reengineering Team December 8, 2010 Patent Process Reengineering Team and Patent End-To-End Processing Team The Biotechnology.
After Final Practice Linda M. Saltiel June 2, 2015.
Compact Prosecution Bennett Celsa TC Quality Assurance Specialist (December 2009)
Leon Radomsky The Marbury Law Group PLLC Interview Practice and Knowing the USPTO.
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
FY09 Restriction Petition Update; Comparison of US and National Stage Restriction Practice Julie Burke TC1600 Quality Assurance Specialist
Pilot Concerning Public Submission of Peer Reviewed Prior Art Jack Harvey Director, TC 2100.
1 Restriction Petition Survey; A Few Helpful Hints Julie Burke TC1600 Special Program Examiner
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
Patent Fee Proposal Patent Public Advisory Committee Hearing November 19, 2015.
Investigational Devices and Humanitarian Use Devices June 2007.
101 Issues in the US Middleton Reutlinger MIDDLETON REUTLINGER
LibQUAL+ ® Survey Administration LibQUAL+® Exchange Northumbria Florence, Italy August 17, 2009 Presented by: Martha Kyrillidou Senior Director, Statistics.
McDermott Will & Emery Roundtable Updates from the PTAB February 25, 2013 James Donald Smith Chief Administrative Patent Judge Patent Trial and Appeal.
Total # of Patent Applications226 Total # of Registered Reviewers279 Total # of Prior Art References Submitted603 Total # of Prior Art References.
1 Biotech/Chem/Pharm Customer Partnership Meeting June 15, 2005 USPTO Study on Restriction Reform and Update on TC1600 Restriction Practice Action Plan.
June 13, Biotechnology/Chemical/Pharmaceutical Customer Partnership USPTO Study on Restriction Reform and TC1600 Restriction Practice Action Plan.
1 Drivers for Implementation of TC 1600 Restriction Practice Action Plan: Public comments from bar groups, and customer partnerships starting before the.
Report to the AIPLA’s IP Practice in Japan Committee January 22, 2012 USPTO Appeal Process: Appeal Strategies and New Rules Presented by: Stephen S. Wentsler.
1. Video Conference Interviews 2 Sean Hagan Director of the Midwest Regional United States Patent and Trademark Office Webinar for Knobbe Martens January.
1 PPAC Patents Operations Update Peggy Focarino Deputy Commissioner for Patents July 8, 2010.
Accelerated Patent Examination: Green Technology A Summary of Global Initiatives, with specific discussion of the US Speaker: Matt Prater Preparation help.
1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600.
Prosecution Luncheon Patent July 2016
NATIONAL ASSOCIATION OF REGULATORY UTILITY COMMISSIONERS REGULATORY PARTNERSHIP PROGRAM Partnership between: PUBLIC UTILITIES COMMISSION OF OHIO (PUCO)
Prosecution Luncheon Patent August 2016
USPTO Appeal Process: Appeal Strategies and New Rules
American Intellectual Property Lawyers Association 2015 Spring Meeting Los Angeles, California April 29 – May 2, 2015 John Cabeca Director of the.
Biotech/Chem/Pharm Customer Partnership Meeting, March 15, 2005
Los Angeles Intellectual Property Law Association
I. Review of TC1600 Restriction Practice Action Plan
Boston Patent Law Association Annual Meeting
Presentation transcript:

Biotech Customer Partnership August 3, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)

2 TC1600 Restriction Action Plan: Update

3 Review of TC1600 Restriction Practice Action Plan The action plan includes 5 initiatives: 1.Publish Examples Of Claim Sets 2.Emphasis On Rejoinder Practice 3.Examiner Training On Restriction Practice 4.Enhanced Review Of Restriction Requirements 5.Continuous Assessment

4 Review of TC1600 Restriction Practice Action Plan-progress 1.Publish examples of claim sets –Provide examples that do not present a serious burden on the office  We are working on this and anticipate publication this FY

5 Review of TC1600 Restriction Practice Action Plan-progress 2.Emphasis on rejoinder practice –Provide a new rejoinder paragraph –Remind applicants of their options on rejoinder  This has been implemented

6 Review of TC1600 Restriction Practice Action Plan-progress 3.Examiner training on restriction practice –Emphasize proper restriction practices Claim groupings and support/formulation of restriction requirements –Provide art unit/workgroup specific examples –Publish materials  We will train the examiners once the training materials, which are nearing completion, are finalized. After training is completed we will post the training materials on the USPTO web site.

7 Review of TC1600 Restriction Practice Action Plan-progress 4.Enhanced review of restriction requirements –Review art units with high number of restrictions and indications of inconsistent requirements –Includes reviewing restrictions in 2 nd and subsequent actions  This has been implemented

8 Review of TC1600 Restriction Practice Action Plan-progress 5.Continuous assessment –Collect data from reviews and samplings –Survey customers on impact of action plan  We are currently collecting data from reviews

9 Appeals Conferences

10 Appeals Conferences An appeals conference is mandatory in all cases in which an acceptable appeal brief has been filed and the examiner in charge of the application is going to proceed with the appeal and write an examiner’s answer (MPEP 1208).

11 Appeals Conferences The participants in an appeals conference are: –The examiner –The examiner’s SPE –A conferree The conferee is preferably another SPE, SPRE, QAS, or TCPS. However, the conferee may also be a primary examiner having sufficient experience and knowledge to be of assistance in the consideration of the merits of the issues on appeal.

12 Appeals Conferences The Board of Patent Appeals and Interferences will return all cases that do not include the stamp and initials of the conferees to the technology center.

13 Appeals Conference Outcomes A Notice of Allowance may be issued. An Examiner’s Answer may be issued. A new action may be issued.

14 Appeals Conference Outcomes- data FY03: –Exmr. Answrs 426 (44.6%) –Re-openings 282 (29.5%) –Allowances 237 (24.8%) FY04 (from a month on so ago): –Exmr. Answrs 229 (60.1%) –Re-openings 84 (22.0%) –Allowances 61 (16.0%)